** = Publications listed in SCI/SSCI/Pubmed
** Dubrall, D; Branding, NL; Mathey, CM; Weber, AM; Steffens, M; Below, M; Schmid, M; Wedi, B; Wieczorek, D; Amann, PM; Löffler, H; Koch, L; Schöffl, C; Dickel, H; Ganjuur, N; Hornung, T; Buhl, T; Aygören-Pürsün, E; Wurpts, G; Greve, J; Nöthen, MM; Forstner, AJ; Sachs, B
Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema.
Clin Transl Allergy. 2025; 15(5):e70058
Doi: 10.1002/clt2.70058
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Eigentler, T; Thomas, I; Samoylenko, I; Erdmann, M; Heinzerling, L; Ochsenreither, S; Krauss, J; Oberoi, A; Robert, C; Lebbe, C; Martin-Liberal, J; Koch, L; Richtig, E; Terheyden, P; Weishaupt, C; Mohr, P; Semiletova, Y; Perez, CL; Brossart, P; Bauernfeind, FG; Fluck, M; Poltoratskiy, A; Sekacheva, M; Soria, A; Schmitt-Bormann, B; Gonzalez, M; Hess, J; Wengenmayer, P; Seibel, T; Koch, SD; Quintini, G; Codó, P; Falk, M; Schönborn-Kellenberger, O; Gnad-Vogt, U
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
J IMMUNOTHER CANCER. 2025; 13(2): e009352
Doi: 10.1136/jitc-2024-009352
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Arzt-Gradwohl, L; Čerpes, U; Schadelbauer, E; Schöffl, C; Herzog, SA; Schrautzer, C; Bokanovic, D; Koch, L; Laipold, K; Binder, B; Sturm, G
A Safe and Efficient 7-Week Immunotherapy Protocol With Aluminum Hydroxide Adsorbed Bee Venom.
Allergy. 2025;
Doi: 10.1111/all.16528
Web of Science
PubMed
FullText
FullText_MUG
** Brandlmaier, M; Hoellwerth, M; Silly, T; Hoeller, C; Koch, L; Richtig, E; Binder, K; Lange-Asschenfeldt, B; Barta, M; Schmid-Simbeck, M; Froehlich, F; Dummer, R; Muigg, L; Hitzl, W; Koelblinger, P
Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis.
J Eur Acad Dermatol Venereol. 2024;
Doi: 10.1111/jdv.20384
Web of Science
PubMed
FullText
FullText_MUG
** Mathey, CM; Maj, C; Eriksson, N; Krebs, K; Westmeier, J; David, FS; Koromina, M; Scheer, AB; Szabo, N; Wedi, B; Wieczorek, D; Amann, PM; Löffler, H; Koch, L; Schöffl, C; Dickel, H; Ganjuur, N; Hornung, T; Buhl, T; Greve, J; Wurpts, G; Aygören-Pürsün, E; Steffens, M; Herms, S; Heilmann-Heimbach, S; Hoffmann, P; Schmidt, B; Mavarani, L; Andresen, T; Sørensen, SB; Andersen, V; Vogel, U; Landén, M; Bulik, CM; Bygum, A; Magnusson, PKE; von, Buchwald, C; Hallberg, P; Rye, Ostrowski, S; Sørensen, E; Pedersen, OB; Ullum, H; Erikstrup, C; Bundgaard, H; Milani, L; Rasmussen, ER; Wadelius, M; Ghouse, J; Sachs, B; Nöthen, MM; Forstner, AJ, , Estonian, Biobank, Research, Team;DBDS, Genomic, Consortium
Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus.
J Allergy Clin Immunol. 2024;
Doi: 10.1016/j.jaci.2023.11.921
Web of Science
PubMed
FullText
FullText_MUG
** Barth, DA; Moik, F; Steinlechner, S; Posch, F; Mayer, MC; Sandner, AM; Berton, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
J Immunother Cancer. 2023; 11(12):
Doi: 10.1136/jitc-2023-007765
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Laipold, K; Arzt-Gradwohl, L; Sturm, EM; Aberer, W; Aumayr, M; Hemmer, W; Cerpes, U; Sturm, GJ
Molecular allergy diagnosis is sensitive and avoids misdiagnosis in patients sensitized to seasonal allergens
CLIN TRANSL ALLERGY. 2023; 13(3): e12231
Doi: 10.1002/clt2.12231
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchacher, L; Richtig, G; Dernoscheg, M; Richtig, E; Koch, L
Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma.
J Eur Acad Dermatol Venereol. 2023; 37(5):e605-e607
Doi: 10.1111/jdv.18871
Web of Science
PubMed
FullText
FullText_MUG
** Mutz-Rabl, CG; Koelblinger, P; Koch, L
Immunotherapy for metastatic melanoma-from little benefit to first-line treatment
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00881-6
Web of Science
FullText
FullText_MUG
** Barth, D; Moik, F; Steinlechner, SM; Posch, F; Schlintl, V; Koch, L; John, N; Wurm, R; Pichler, M; Bauernhofer, T; Reimann, P; Wohlkönig, C; Richtig, E; Winder, T; Preusser, M; Jost, PJ; Ay, C; Gerger, A; Terbuch, A; Riedl, JM
Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
ANN ONCOL. 2023; 34: S259-S259.-Annual Meeting of the European-Society-for-Medical-Oncology (ESMO); OCT 20-24, 2023; Barcelona, SPAIN.
Doi: 10.1016/j.annonc.2023.09.2917
[Poster]
Web of Science
FullText
FullText_MUG
** Cerpes, U; Arzt-Gradwohl, L; Koch, L; Schöffl, C; Schadelbauer, E; Laipold, K; Schrautzer, C; Jungwirth, E; Binder, B; Sturm, G
Accelerated 7-week outpatient up-dosing protocol with aluminium hydroxide adsorbed bee venom
ALLERGY. 2023; 78: -Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 09-11, 2023; Hamburg, GERMANY.
[Poster]
Web of Science
** Debus, D; Rohrer, P; Grote, C; Kähler, KC; Koch, L; Reichenbach, F; Terheyden, P; Nguyen, VA
Retrospective individual case reports on the treatment of patients with advanced BRAFV600-mutant malignant melanoma with encorafenib plus binimetinib (REMINISCENCE): focus on patients with brain metastases
J DTSCH DERMATOL GES. Abstracts. 2023; 21(S4):79-80.-33. Deutschen Hautkrebskongresses (ADO-Jahrestagung); SEP 6-9, 2023; Hamburg, GERMANY.
[Poster]
Web of Science
** Sadoghi, B; Koch, L; Kalinina, P
Anton Luger Dissertationspreise der ÖGDV 2022.
J Dtsch Dermatol Ges. 2023; 21(3): 321-323.
Doi: 10.1111/ddg.15039_g
Web of Science
PubMed
FullText
FullText_MUG
** Mathey, CM; Maj, C; Scheer, AB; Fazaal, J; Wedi, B; Wieczorek, D; Amann, PM; Löffler, H; Koch, L; Schöffl, C; Dickel, H; Ganjuur, N; Hornung, T; Forkel, S; Greve, J; Wurpts, G; Hallberg, P; Bygum, A; Von, Buchwald, C; Karawajczyk, M; Steffens, M; Stingl, J; Hoffmann, P; Heilmann-Heimbach, S; Mangold, E; Ludwig, KU; Rasmussen, ER; Wadelius, M; Sachs, B; Nöthen, MM; Forstner, AJ
Molecular Genetic Screening in Patients With ACE Inhibitor/Angiotensin Receptor Blocker-Induced Angioedema to Explore the Role of Hereditary Angioedema Genes.
Front Genet. 2022; 13: 914376
Doi: 10.3389/fgene.2022.914376
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buchacher, L; Richtig, G; Schöffl, C; Richtig, E; Koch, L
Long-term adherence to melanoma follow-up examinations - a telephone survey.
J Eur Acad Dermatol Venereol. 2022; 36(9):e710-e712
Doi: 10.1111/jdv.18177
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Plaschg, K; Fuchs, A; Wood, J; Fautz, R; Kränke, B; Aberer, W; Blömeke, B
Tolerability and Cross-reactivity of 3 New Hair Colorants in p-Phenylenediamine-Allergic Individuals.
Dermatitis. 2022; 33(2): e18-e20.
Doi: 10.1097/DER.0000000000000867
Web of Science
PubMed
FullText
FullText_MUG
** Sturm, GJ; Arzt-Gradwohl, L; Čerpes, U; Koch, L; Bokanovic, D; Laipold, K; Vollmann, J; Binder, B
Prospective studies are needed to elucidate the clinical impact of predominant Api m 10 sensitization.
Allergy. 2022; 77(2):687-689
Doi: 10.1111/all.15151
Web of Science
PubMed
FullText
FullText_MUG
** Gruber, V; Binder, B; Koch, L
Horse or Zebra?
J Dtsch Dermatol Ges. 2022;
Doi: 10.1111/ddg.14804
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Jungwirth, E; Kupsa, R; Kränke, B; Cerroni, L; Koch, L
Unusual contact dermatitis after SARS-CoV-2 vaccinations.
Contact Dermatitis. 2022;
Doi: 10.1111/cod.14084
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Fink-Puches, R; Cerroni, L; Aigelsreiter, A; Sadoghi, B
[Orchiectomy due to early syphilis].
Urologie. 2022; 61(7):767-769
Doi: 10.1007/s00120-022-01776-w
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Plaschg, K; Talakic, E; Stradner, MH
Palmar papules - a warning sign
DERMATOLOGIE. 2022;
Doi: 10.1007/s00105-022-05032-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Debus, D; Alter, M; Dernoscheg, MT; Rohrer, P; Koch, L; Nguyen, VA; Terheyden, P
Retrospective Single Case Reports on the Treatment of Advanced BRAFV600-mutated Malignant Melanoma with Encorafenib plus Binimetinib (REMINISCENCE)
ONCOL RES TREAT. 2022; 45(SUPPL 3):237-237.NOV 13-16, 2022; Berlin, GERMANY.
[Poster]
Web of Science
** Grote, C; Debus, D; Bluhm, L; Koch, L; Alter, M; Dernoscheg, M; Nepel, C; Rohrer, P; Kahler, K; Tuting, T; Gengen-Bacher, L; Nguyen, V; Terheyden, P
Retrospective Survey of Individual Case Reports on Treatment Situations in Patients with locally advanced or metastatic, BRAFV600-mutated Melanoma with Encorafenib and Binimetinib (REMINISCENCE).
J DTSCH DERMATOL GES. 2022; 20: 30-30.-ADO 2022; SEP 14-17, 2020; Hannover.
[Poster]
Web of Science
** Riedl, JM; Barth, D; Steinlechner, S; Moik, F; Posch, F; Schlintl, V; Mayer, MC; Sandner, AM; Berton, F; Koch, L; John, N; Wurm, R; Pichler, M; Absenger, G; Jost, PJ; Wohlkonig, C; Richtig, E; Winder, T; Gerger, A; Terbuch, A
Early CRP Kinetics after Initiation of Immune Checkpoint Inhibitors is a predictive Biomarker for Treatment Response independent of the Tumor Antity
ONCOL RES TREAT. 2022; 45(SUPPL 2):228-228.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; Okt 7-10, 2022; Wien.
[Poster]
Web of Science
** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12):
Doi: 10.3390/cancers13123101
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koelblinger, P; Hoellwerth, M; Dernoscheg, MT; Koch, L; Richtig, E; Wanner, M; Nguyen, VA; Ostermann, H; Bauer, JW; Laimer, M
Adjuvant anti-PD-1 antibody treatment in stage III/IV melanoma: real-world experience and health economic considerations
J DTSCH DERMATOL GES. 2021;
Doi: 10.1111/ddg.14511
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ressler, JM; Karasek, M; Koch, L; Silmbrod, R; Mangana, J; Latifyan, S; Aedo-Lopez, V; Kehrer, H; Weihsengruber, F; Koelblinger, P; Posch, C; Kofler, J; Michielin, O; Richtig, E; Hafner, C; Hoeller, C
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
J Immunother Cancer. 2021; 9(2):
Doi: 10.1136/jitc-2020-001701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Cerpes, U; Binder, B; Cerroni, L
Disseminated bullous impetigo in atopic dermatitis ('eczema staphylococcatum').
J Eur Acad Dermatol Venereol. 2021; 35(4):e280-e282
Doi: 10.1111/jdv.17043
Web of Science
PubMed
FullText
FullText_MUG
** Arzt-Gradwohl, L; Cerpes, U; Koch, L; Laipold, K; Vollmann, J; Binder, B; Sturm, GJ
Treatment failure in bee venom immunotherapy: is it only Api m 10?
ALLERGOLOGIE. 2021; 44(2):154-155.
[Onlinepräsentation]
Web of Science
** Koch, L; Laipold, K; Arzt-Gradwohl, L; Cerpes, U; Sturm, EM; Sturm, GJ
Sensitivity of the Allergy Explorer version 1 and 2 for the diagnosis of the five most common seasonal inhalant allergens in Austria
ALLERGY. abstract summary. 2021; 76: 64-64.-EACCI Congress 2021; JUL 10-12, 2021; Krakau, POLAND.
[Onlinepräsentation]
Web of Science
FullText
** Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A
Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229.
[Poster]
Web of Science
** Čerpes, U; Arzt-Gradwohl, L; Schrautzer, C; Koch, L; Bokanovic, D; Laipold, K; Tripolt, P; Binder, B; Sturm, GJ
Simultaneous up-dosing of bee and vespid venom immunotherapy is safe.
Allergy. 2020; 75(3):721-723
Doi: 10.1111/all.14079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Laipold, K; Arzt-Gradwohl, L; Čerpes, U; Sturm, EM; Aberer, W; Sturm, GJ
IgE multiplex testing in house dust mite allergy is utile, and sensitivity is comparable to extract-based singleplex testing.
Allergy. 2020; 75(8):2091-2094
Doi: 10.1111/all.14271
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schrautzer, C; Arzt-Gradwohl, L; Bokanovic, D; Schwarz, I; Čerpes, U; Koch, L; Herzog, SA; Laipold, K; Binder, B; Aberer, W; Sturm, GJ
A safe and efficient 7-week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom.
Allergy. 2020; 75(3):678-680
Doi: 10.1111/all.14012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakic, E; Richtig, G; Richtig, E; Rohrer, P; Koch, L; Wolf, I; Koch, C; Rainer, B; Koeller, M; Pichler, M; Kashofer, K; Aigelsreiter, A
Feasibility and first results of circulating tumor DNA as a marker for treatment response in metastatic melanoma patients using Next Generation Sequencing.
ONCOL RES TREAT. 2020; 43(SUPPL 4):166-167.
[Onlinepräsentation]
Web of Science
** Cerpes, U; Arzt-Gradwohl, L; Koch, L; Laipold, K; Tripolt, P; Sturm, GJ
Is the sensitivity of multiplex testing sufficient to diagnose bee and vespid venom allergy?
ALLERGY. 2020; 75: 153-153.-European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI); JUN 06-08, 2020; London, ENGLAND.
[Poster]
Web of Science
** Koch, L; Laipold, K; Arzt-Gradwohl, L; Cerpes, U; Sturm, EM; Aberer, W; Sturm, GJ
IgE multiplex testing in house dust mite allergy is utile and sensitivity is comparable to extract-based singleplex testing.
ALLERGY. 2020; 75: 159-159.-European-Academy-of-Allergology-and-Clinical-Immunology Digital Congress (EAACI); JUN 06-08, 2020; London, ENGLAND.
[Poster]
Web of Science
** Mathey, C; Forstner, AF; Maj, C; Borisov, O; Rassmussen, ER; Bygum, A; von Buchwald, C; Wadelius, M; Hallberg, P; Karawajczyk, M; Eriksson, N; Wedi, B; Wieczorek, D; Amann, PM; Loffler, H; Koch, L; Schoffl, C; Evertz, N; Greve, J; Wurpts, G; Moebus, S; Krawitz, PM; Stingl, J; Sachs, B; Nothen, MM
Molecular genetic investigation of ACE inhibitor induced angioedema.
EUR J HUM GENET. 2020; 28(SUPPL 1): 823-824.
[Poster]
Web of Science
FullText
** Di Prete, M; Koch, L; Cerroni, L
Keratotic Nodules and Plaques on the Lower Extremities: Challenge.
AM J DERMATOPATH. 2020; 42(8): e113-e114-e113-e114.
Doi: 10.1097/DAD.0000000000001669
Web of Science
PubMed
FullText
FullText_MUG
** Di Prete, M; Koch, L; Cerroni, L
Keratotic Nodules and Plaques on the Lower Extremities: Answer.
AM J DERMATOPATH. 2020; 42(8): 613-613.
Doi: 10.1097/DAD.0000000000001668
Web of Science
PubMed
FullText
FullText_MUG
** Schöffl, C; Wiednig, M; Koch, L; Blagojevic, D; Duschet, P; Hawranek, T; Kinaciyan, T; Öllinger, A; Aberer, W
Hereditary angioedema in Austria: prevalence and regional peculiarities.
J Dtsch Dermatol Ges. 2019; 17(4):416-423
Doi: 10.1111/ddg.13815
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Richtig, G; Ramelyte, E; Koch, L; Greinix, H; Ferrone, S; Dummer, R; Richtig, E
Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
J Eur Acad Dermatol Venereol. 2019; 33(10):e381-e383-e381-e383
Doi: 10.1111/jdv.15675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schöffl, C; Koch, L; Cerroni, L; Fink-Puches, R
Hypokeratotic lesion on the palm.
J Dtsch Dermatol Ges. 2019; 17(7):752-754
Doi: 10.1111/ddg.13881
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Arzt-Gradwohl, L; Schrautzer, C; Cerpes, U; Koch, L; Laipold, K; Vollmann, J; Binder, B; Sturm, G
Treatment failure in bee venom immunotherapy: Too early to reach any conclusion regarding Api M 10
ALLERGY. 2019; 74: 15-15.
[Oral Communication]
Web of Science
** Cerpes, U; Arzt-Gradwohl, L; Schrautzer, C; Koch, L; Laipold, K; Tripolt, P; Binder, B; Sturm, G
The rate of adverse events is comparable between simultaneous bee and vespid venom immunotherapy and bee venom mono-immunotherapy
ALLERGY. 2019; 74: 235-235.
[Poster]
Web of Science
** Hoeller, C; Ressler, JM; Karasek, M; Lopez, VA; Koch, L; Kehrer, H; Koelblinger, P; Weihsengruber, F; Kofler, J; Richtig, E; Michielin, OA; Hafner, C
Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland
ANN ONCOL. 2019; 30: 548-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN.
[Poster]
Web of Science
** Tripolt, P; Arzt-Gradwohl, L; Schrautzer, C; Cerpes, U; Koch, L; Laipold, K; Binder, B; Sturm, G
Differences and similarities between large local reactions and systemic sting reactions
ALLERGY. Allergy. 2019; 74: 235-236.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); JUN 01-05, 2019; Lisbon, PORTUGAL.
[Poster]
Web of Science
** Coenraads, PJ; Aberer, W; Cristaudo, A; Diepgen, T; Holden, C; Koch, L; Schuttelaar, ML; Weisshaar, E; Fuchs, A; Schlotmann, K; Goebel, C; Blömeke, B; Krasteva, M
Allergy Alert Test for p-Phenylenediamine-Allergic Hair Dye Users.
Dermatitis. 2018; 29(5):250-257
Doi: 10.1097/DER.0000000000000405
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Schöffl, C; Aberer, W; Massone, C
Methotrexate Treatment for Pityriasis Rubra Pilaris: A Case Series and Literature Review.
ACTA DERM-VENEREOL. 2018; 98(5): 501-505.
Doi: 10.2340/00015555-2885
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Laipold, K; Schrautzer, C; Arzt, L; Cerpes, U; Sturm, EM; Aberer, W; Binder, B; Sturm, GJ
Comparison of sIgE levels to mite extracts and allergen components between asthmatic and non-asthmatic house dust mite allergic patients
ALLERGY. 2018; 73: 551-551.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science
** Koch, L; Laipold, K; Schrautzer, C; Arzt, L; Cerpes, U; Sturm, EM; Aberer, W; Binder, B; Sturm, GJ
Comparison of molecular singleplex and multiplex analysis in the diagnosis of house dust mite allergy
ALLERGY. 2018; 73: 191-192.-Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI); MAY 26-30, 2018; Munich, GERMANY.
[Poster]
Web of Science
** Aberer, W; Holzweber, F; Hemmer, W; Koch, L; Bokanovic, D; Fellner, W; Altmann, F
Inhibition of cross-reactive carbohydrate determinants (CCDs) enhances the accuracy of in vitro allergy diagnosis.
Allergol Select. 2017; 1(2): 141-149.
Doi: 10.5414/ALX01638E
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Richtig, G; Richtig, E; Kashofer, K; Koch, L; Winter, G; Hoefler, G; Pichler, M; Ehall, B; Grübler, MR; Heinemann, A; Aigelsreiter, A
Testing and clinical implications for non-V600 BRAF mutations in metastatic NRASmt melanoma.
Br J Dermatol. 2017; 177(3):860-861
Doi: 10.1111/bjd.15222
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Aberer, W
[Allergic contact dermatitis of the scalp].
Hautarzt. 2017; 68(6):466-471
Doi: 10.1007/s00105-017-3975-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Kränke, B; Aberer, W
Potential drug-drug interactions and adverse drug reactions in dermatological inpatients.
J Dtsch Dermatol Ges. 2016; 14(11):1122-1129
Doi: 10.1111/ddg.12915
Web of Science
PubMed
FullText
FullText_MUG
** Koch, L; Lichem, R; Cerroni, L; Aberer, W; Massone, C
Dermatitis, nonmelanoma skin cancer and leg ulcers.
CLIN EXP DERMATOL. 2016; 41(8): 943-944.
Doi: 10.1111/ced.12896
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Richtig, G; Ehall, B; Koch, L; Richtig, E; Winter, G; Eder, S; Kashofer, K; Heinemann, A; Hoefler, G; Aigelsreiter, A
The clinical relevance of testing for non-V600E BRAF mutations in melanoma-a single center experience
VIRCHOWS ARCH. 2016; 469: S309-S309.
[Oral Communication]
Web of Science
** Riding, G; Ehall, B; Koch, L; Richtig, E; Winter, G; Eder, S; Kashofer, K; Heinemann, A; Hoefler, G; Aigelsreiter, A
The relevance of BRAF exon 11 testing in melanoma-single center experience
VIRCHOWS ARCH. 2016; 469: S193-S193.
[Poster]
Web of Science
** Aberer, W; Holzweber, F; Hemmer, W; Koch, L; Bokanovic, D; Fellner, W; Altmann, F;
Inhibition of cross-reactive carbohydrate determinants (CCDs) enhances the selectivity of in vitro allergy diagnosis.
ALLERGOLOGIE. 2014; 37(2): 46-+.
Doi: 10.5414/ALX01638
Web of Science
FullText
FullText_MUG
Google Scholar
** Koch, L; Aberer, W
Comparability and quality of IgE-based in vitro allergy diagnosis: 25 years of external quality assessment.
Wien Klin Wochenschr. 2014; 126(19-20):634-641
Doi: 10.1007/s00508-014-0594-5
Web of Science
PubMed
FullText
FullText_MUG
** Koch, LD; Knoll, F; Hartmann, G; Lhotta, K
Recurrent exit-site infection due to Staphylococcus lugdunensis--a virulent coagulase-negative Staphylococcus.
Perit Dial Int. 2011; 31(3): 372-373.
Doi: 10.3747/pdi.2010.00272
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG